搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 小时
FDA alerting vets about arthritis drug after hundreds of reports of health problems in dogs
The FDA is alerting veterinarians about reports of health problems in dogs, including hundreds of deaths, tied to a drug for ...
4 小时
Sickle cell disease drug's withdrawal leads to suits against Pfizer
A once-groundbreaking sickle cell disease drug — at the center of a $5.4 billion acquisition two years ago — is the subject ...
Zacks.com on MSN
6 小时
BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer
Bristol Myers Squibb BMY announced that the European Commission has approved the combination of its blockbuster ...
24/7 Wall St
6 小时
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
24/7 Wall St
7 小时
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...
8 小时
Bio-Thera Solutions Partners With Tabuk Pharmaceuticals To Commercialize BAT2206, A Stelara ...
BAT2206 is a proposed biosimilar to Jansen's Stelara®. Bio-Thera has filed for regulatory approval of BAT2206 with the China ...
WGN Radio
9 小时
Russian cargo ship sinks in the Mediterranean, leaving 2 crew missing
A Russian cargo ship sank in the Mediterranean Sea between Spain and Algeria, leaving two crew members missing, Spain’s maritime rescue agency and the Russian Foreign Ministry ...
9 小时
Anavex Life Sciences: Why I Am Still Not Buying The Bull Thesis
Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...
12 小时
AstraZeneca, Daiichi pull EU marketing application for lung cancer drug, Dato-DXd
AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) withdraw EU marketing application for lung cancer therapy Dato-DXd. Read more ...
pharmaphorum
12 小时
Quality compliance in the digital era
Quality compliance in the pharma industry is foundational to guaranteeing safe and effective products. For years, Good ...
12 小时
AstraZeneca withdraws EU application for experimental lung cancer drug
Feedback from the EU indicated that the trial results, which the application was based on, showed that the drug did not ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈